微小 RNA 在胰腺癌中的作用：病理、诊断和治疗意义。
MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
机构信息
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
出版信息
Cancer Lett. 2010 Jun 1;292(1):8-16. doi: 10.1016/j.canlet.2009.11.010. Epub 2009 Dec 9.
Abstract
MicroRNAs (miRNAs) are a group of small non-coding RNA molecules of 17-25 nucleotides (nt) in length, predicted to control the activity of about 30% of all protein-coding genes in mammals. Altered expressions of miRNAs are reported in various cancers and may associate with cancer pathogenesis, apoptosis, and cell growth, thereby functioning as either tumor suppressors or oncogenes. Recent reports showed that deregulation of miRNA contribute to tumor development and progression and hence, have diagnostic and prognostic value in several human malignancies. This review discusses the current status of miRNA in pancreatic cancer development, progression, diagnosis, and therapy.
摘要
微小 RNA（miRNA）是一组长度为 17-25 个核苷酸（nt）的小型非编码 RNA 分子，据预测可以控制哺乳动物中大约 30%的所有蛋白质编码基因的活性。在各种癌症中报道了 miRNA 的表达改变，并且可能与癌症发病机制、细胞凋亡和细胞生长有关，因此作为肿瘤抑制因子或癌基因发挥作用。最近的报告表明，miRNA 的失调有助于肿瘤的发展和进展，因此在几种人类恶性肿瘤中具有诊断和预后价值。本综述讨论了 miRNA 在胰腺癌发展、进展、诊断和治疗中的现状。
相似文献
1
MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
Cancer Lett. 2010 Jun 1;292(1):8-16. doi: 10.1016/j.canlet.2009.11.010. Epub 2009 Dec 9.
2
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Adv Drug Deliv Rev. 2015 Jan;81:16-33. doi: 10.1016/j.addr.2014.10.020. Epub 2014 Oct 23.
3
[Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].
Zhonghua Zhong Liu Za Zhi. 2020 Nov 23;42(11):903-906. doi: 10.3760/cma.j.cn112152-20190313-00152.
4
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
Gastroenterology. 2014 Jan;146(1):268-77.e18. doi: 10.1053/j.gastro.2013.10.010. Epub 2013 Oct 9.
5
Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.
6
Targeting microRNAs in pancreatic cancer: microplayers in the big game.
Cancer Res. 2013 Nov 15;73(22):6541-7. doi: 10.1158/0008-5472.CAN-13-1288. Epub 2013 Nov 7.
7
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
Genes (Basel). 2019 Sep 25;10(10):752. doi: 10.3390/genes10100752.
8
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
World J Surg. 2009 Apr;33(4):698-709. doi: 10.1007/s00268-008-9833-0.
9
miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
Expert Rev Respir Med. 2011 Oct;5(5):699-709. doi: 10.1586/ers.11.55.
10
Exploring miRNA based approaches in cancer diagnostics and therapeutics.
Crit Rev Oncol Hematol. 2016 Feb;98:12-23. doi: 10.1016/j.critrevonc.2015.10.003. Epub 2015 Oct 8.
引用本文的文献
1
Role of noncoding RNA and protein interaction in pancreatic cancer.
Chin Med J (Engl). 2025 May 5;138(9):1019-1036. doi: 10.1097/CM9.0000000000003587. Epub 2025 Apr 10.
2
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.
Biomedicines. 2024 Aug 1;12(8):1713. doi: 10.3390/biomedicines12081713.
3
MicroRNA-485-5p targets keratin17 to regulate pancreatic cancer cell proliferation and invasion via the FAK / SRC / ERK pathway.
J Cancer. 2024 Feb 17;15(7):2033-2044. doi: 10.7150/jca.90689. eCollection 2024.
4
Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells.
Biomolecules. 2023 Dec 20;14(1):4. doi: 10.3390/biom14010004.
5
Molecular Aberrations in Periampullary Carcinoma.
Indian J Surg Oncol. 2017 Sep;8(3):348-356. doi: 10.1007/s13193-017-0645-2. Epub 2017 Mar 21.
6
Potential role of microRNAs in pancreatic cancer manifestation: a review.
J Egypt Natl Canc Inst. 2022 Jun 20;34(1):26. doi: 10.1186/s43046-022-00127-2.
7
Syntenin Regulated by miR-216b Promotes Cancer Progression in Pancreatic Cancer.
Front Oncol. 2022 Jan 28;12:790788. doi: 10.3389/fonc.2022.790788. eCollection 2022.
8
Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers.
Pharmaceutics. 2021 Nov 23;13(12):1987. doi: 10.3390/pharmaceutics13121987.
9
Exosomes in the Pathogenesis, Diagnosis and Treatment of Pancreatic Diseases.
CellR4 Repair Replace Regen Reprogram. 2014;2(1). Epub 2014 Feb 8.
10
Apoptosis induction and proliferation inhibition by silibinin encapsulated in nanoparticles in MIA PaCa-2 cancer cells and deregulation of some miRNAs.
Iran J Basic Med Sci. 2020 Apr;23(4):469-482. doi: 10.22038/ijbms.2020.39427.9349.
本文引用的文献
1
Causes and consequences of microRNA dysregulation in cancer.
Nat Rev Genet. 2009 Oct;10(10):704-14. doi: 10.1038/nrg2634.
2
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
Genes Dev. 2009 Sep 15;23(18):2152-65. doi: 10.1101/gad.1820109.
3
Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Gastroenterology. 2009 Dec;137(6):2136-45.e1-7. doi: 10.1053/j.gastro.2009.08.065. Epub 2009 Sep 10.
4
Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
Pancreas. 2009 Oct;38(7):e190-9. doi: 10.1097/MPA.0b013e3181ba82e1.
5
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.
Cancer Prev Res (Phila). 2009 Sep;2(9):807-13. doi: 10.1158/1940-6207.CAPR-09-0094. Epub 2009 Sep 1.
6
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PLoS One. 2009 Aug 28;4(8):e6816. doi: 10.1371/journal.pone.0006816.
7
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
Cancer Res. 2009 Aug 15;69(16):6704-12. doi: 10.1158/0008-5472.CAN-09-1298. Epub 2009 Aug 4.
8
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.
Int J Cancer. 2010 Jan 1;126(1):73-80. doi: 10.1002/ijc.24687.
9
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
Mol Cancer Ther. 2009 May;8(5):1067-74. doi: 10.1158/1535-7163.MCT-08-0592. Epub 2009 May 12.
10
Genetic variation of miRNA sequence in pancreatic cancer.
Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):407-13. doi: 10.1093/abbs/gmp023.
Zotero 插件